Oral Answers to Questions

Barry Sheerman Excerpts

Thursday 20th April 2017 Commons Chamber

[Andrea Leadsom]

It is a great shame that the hon. Lady criticises this Government, who since 2011 have committed more than £2 billion to increase the uptake of ultra-low emission vehicles and support greener transport schemes and have set out how we will improve air quality through a new programme of clean zones. In addition, in the autumn statement we announced a further £290 million to support low-emission buses and taxis, retrofitting and alternative fuels; and, as I say, we will consult on our plans to improve nitrogen oxide emissions very shortly.

[Mr Barry Sheerman (Huddersfield) (Lab/Co-op)]

I do not want to be intemperate with the Secretary of State, but this is just so much pie in the sky. Every time we have Environment, Food and Rural Affairs questions, she says that something will happen soon. When are we going to have our big natural environment report? When are we going to stop people being poisoned in our cities and towns like Huddersfield, and when are we going to see action—now, not next week, next month or next year?

[Andrea Leadsom]

Let me be very clear: the Government are totally committed to cutting harmful emissions that worsen our air quality. We have made great progress already in the past decade, which is more than the Labour Government did. Emissions went up on their watch. We absolutely recognise that there is more to do and we will publish our proposals very soon.

--- Later in debate ---

[George Eustice]

As I said in response to the earlier question, the evidence is fairly clear. EFSA has studied the matter, and it believes that glyphosate is safe. It has always been the UK’s position to follow the science and the evidence on pesticide decisions, which is why we support the reauthorisation of glyphosate. We will continue to have an evidence-based, science-based approach to these issues when we leave the EU.

[Mr Barry Sheerman (Huddersfield) (Lab/Co-op)]

Does the Secretary of State agree that we need good science, good technology and good innovation? What will she do about the fact that ChemChina has taken over Syngenta, a leading scientific research company largely based in my constituency but with research centres in Jealott’s Hill? Syngenta is the fifth leading innovation company in our country that the Chinese Government have absorbed—ChemChina is not listed on the stock exchange, even in China. What is she going to do about it?

[George Eustice]

The hon. Gentleman will be aware that pesticides and crop protection products are quite an integrated industry across the world. It is not uncommon for foreign-owned companies to be based and operating in the UK. We have some of the world’s best scientific expertise in this area, which is why companies choose to locate here.

--- Later in debate ---

[Mr Speaker]

I rather thought that the hon. Member for Berwick-upon-Tweed (Mrs Trevelyan) was posing a supplementary to Question 1, which was the basis upon which I called her. Never mind; it is not a great sin.

[Mr Barry Sheerman (Huddersfield) (Lab/Co-op)]

rose—

[Mr Speaker]

I have a feeling that the hon. Member for Huddersfield (Mr Sheerman) has an insatiable appetite, and there is no change there.

[Mr Sheerman]

Thank you for that compliment, Mr Speaker.

Is the hon. Member for Gainsborough (Sir Edward Leigh) aware of the real challenge, which has been brought to my attention by the excellent team at Huddersfield royal infirmary, that it is rare cancers that are the problem because they are very expensive to develop drugs for? There is a special case to be made for the treatment of and supply of drugs for these rare cancers. Is the hon. Gentleman aware of that minority group?

[Sir Edward Leigh]

I am aware of that group, and the hon. Gentleman makes an important point. We all hear in our constituency surgeries the heart-rending cases of people who are denied life-saving drugs. I assure the hon. Gentleman that the Comptroller and Auditor General and the Public Accounts Committee are fully aware of this issue and are going to continue to put pressure on the Government with regard to the cancer drugs fund to ensure full transparency so that we are always aware of the problems and can assure affordability for all our citizens.